Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Hold
747
0.05% 76
2026
Q1
$263K Hold
747
0.06% 70
2025
Q4
$245K Buy
+747
New +$237K 0.05% 71
2025
Q2
Sell
-758
Closed -$236K 79
2025
Q1
$236K Buy
+758
New +$224K 0.07% 56
2024
Q4
Sell
-758
Closed -$244K 66
2024
Q3
$244K Sell
758
-10
-1% -$3.27K 0.07% 52
2024
Q2
$240K Buy
768
+10
+1% +$2.94K 0.07% 51
2024
Q1
$235K Sell
758
-75
-9% -$21.9K 0.07% 50
2023
Q4
$263K Buy
+833
New +$227K 0.09% 48

Other funds holding AMGN

The Wealth Group's AMGN Position: Q2 2026 in Review

The Wealth Group held its Amgen (AMGN) position steady in Q2 2026 at 747 shares worth $271K. The position accounts for 0.05% of the portfolio, ranked #76.

The Wealth Group first reported a position in AMGN in Q4 2023 and has held it in 8 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • The Wealth Group held 747 shares of Amgen worth $271K as of Q2 2026.
  • The Wealth Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.05% of The Wealth Group's portfolio in Q2 2026, its #76 holding.
  • The Wealth Group first reported a position in Amgen in Q4 2023 and has held it in 8 quarters since.
  • 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on The Wealth Group's 13F filing for Q2 2026, filed 10 Jul 2026.